Midtrimester amniotic fluid tumor necrosis factor-alpha does not predict small-for-gestational-age infants

American Journal of Reproductive Immunology

Volumn 37, Issue 3, 1997, Pages 236-239

  Spong, Catherine Y ^a,c,d   Scherer, David M ^b,c   Ghidini, Alessandro ^b,c   Pezzullo, John C ^b,c   Salafia, Carolyn M ^b,d   Eglinton, Gary S ^b,c  

^a NICHD   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amniotic fluid; Small for gestational age; TNF

Indexed keywords

ALPHA FETOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMNION FLUID; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIABETES MELLITUS; FEMALE; GENDER; HEART DISEASE; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; MATERNAL AGE; MATERNAL HYPERTENSION; NEWBORN; PARITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; SMOKING; STATISTICAL ANALYSIS;

EID: 0030945424     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00221.x     Document Type: Article

References (12)

1. Goldenberg RL, Nelson KG, Koski JF, Cutter GR. Low birth weight, intrauterine growth retardation, and preterm delivery. Am J Obstet Gynecol 1985; 152:980-984.
2. Lin CC, Su SJ, River LP. Comparison of associated high-risk factors and perinatal outcome between symmetric and asymmetric fetal intrauterine growth retardation. Am J Obstet Gynecol 1991; 164:1535-1542.
3. Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol 1982; 59:624-632.
4. Shiono PH, Klenaboff MA, Graubard BI, Berendes HW, Rhoads GG. Birth weight among women of different ethnic groups. JAMA 1986; 255:48-52.
5. Visser GHA, Huisman A, Saathof PWF, Sinnige HAM. Early fetal growth retardation: Obstetric background and recurrence rate. Obstet Gynecol 1986; 67:40-43.
6. Heyborne KD, Witkin SS, McGregor JA. Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol 1992; 167:920-925.
7. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan Y-CE, Mathison J, et al. Identity of tumor necrosis factor and macrophage-secreted factor cachectin. Nature 1985; 316:552-554.
8. Wennergren M, Wennergren G, Vilbergsson G. Obstetric characteristics and neonatal performance in a four-year small for gestational age population. Obstet Gynecol 1988; 72:615-620.
9. Beyer WH, Number of Observations for t test of difference between two means. In CRC Basic Statistical Tables. 1971, p. 88-89.
10. Ghidini A, Eglinton GS, Spong CY, Jenkins CB, Pezzullo JP, Ossandon M, Mill JF. Elevated midtrimester amniotic fluid tumor necrosis alpha levels: A predictor of preterm delivery. Am J Obstet Gynecol, Abstract 14 1996; 174:307.
11. Vince G, Shorter S, Starkey P, Humphreys J, Clover L, Wilkins T, Sargent I, Redman C. Localization of tumor necrosis factor production in cells at the materno-fetai interface in human pregnancy. Clin Exp Immunol 1992; 88:174-178.
12. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-α is elevated in plasma and amniotic fluid in patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752-1759.